Growth Metrics

Dexcom (DXCM) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 5.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 50.11%
Dec 31, 2025 30.43%
Sep 30, 2025 31.05%
Jun 30, 2025 20.59%
Mar 31, 2025 37.31%
Dec 31, 2024 41.76%
Sep 30, 2024 -6.91%
Jun 30, 2024 65.53%
Mar 31, 2024 95.96%
Dec 31, 2023 -8.08%
Sep 30, 2023 22.18%
Jun 30, 2023 7.29%
Mar 31, 2023 334.08%
Dec 31, 2022 -2.67%
Sep 30, 2022 45.85%
Jun 30, 2022 38.89%
Mar 31, 2022 81.88%
Dec 31, 2021 46.43%
Sep 30, 2021 63.29%
Jun 30, 2021 14.16%
Mar 31, 2021 73.20%
Dec 31, 2020 61.02%
Sep 30, 2020 59.76%
Jun 30, 2020 120.88%
Mar 31, 2020 85.02%
Dec 31, 2019 121.07%
Sep 30, 2019 60.17%
Jun 30, 2019 47.50%
Mar 31, 2019 293.65%
Dec 31, 2018 43.94%
Sep 30, 2018 46.95%
Jun 30, 2018 36.16%
Mar 31, 2018 -65.81%
Dec 31, 2017 69.90%
Sep 30, 2017 46.98%
Jun 30, 2017 32.12%
Mar 31, 2017 28.56%
Dec 31, 2016 44.59%
Sep 30, 2016 143.15%
Jun 30, 2016 181.61%
Mar 31, 2016 64.58%
Dec 31, 2015 45.28%
Sep 30, 2015 70.81%
Jun 30, 2015 66.35%
Mar 31, 2015 32.64%
Dec 31, 2014 39.72%
Sep 30, 2014 54.54%
Jun 30, 2014 64.54%
Mar 31, 2014 36.31%
Dec 31, 2013 32.50%
Sep 30, 2013 29.44%